Skip to main content
Top
Published in: Annals of Hematology 2/2010

01-02-2010 | Original Article

HbA2-Partinico or δ(A2)Pro→Thr, a new genetic variation in the δ-globin gene in cis to the β+ thal IVS-I-110 G>A, and the heterogeneity of δ-globin alleles in double heterozygotes for β- and δ-globin gene defects

Authors: Giuseppina Lacerra, Clelia Scarano, Gennaro Musollino, Rosario Testa, Romeo Prezioso, Daniela G. Caruso, Laura F. Lagona, Emilia Medulla, Maria G. Friscia, Carlo Gaudiano, Clementina Carestia

Published in: Annals of Hematology | Issue 2/2010

Login to get access

Abstract

The study of the alleles of the δ-globin gene is relevant to the prevention of β-thalassemia homozygosis; in fact, the increase of the HbA2 is an invaluable hematological marker of the β-thalassemia heterozygosis and the double heterozygosis for alleles of δ- and β-globin genes can cause the decrease of the HbA2 up to normal or borderline values. We carried out the characterization of alleles of the δ- and β-globin genes, restriction fragment length polymorphism (RFLP) haplotype background, and hematologic phenotype in 23 double heterozygotes belonging to 18 unrelated families. A wide heterogeneity of the δ-globin alleles was detected; seven known alleles in trans to the β-globin gene defects were revealed in 17 out of 18 families, while a new allele in cis to a β-thalassemia allele was detected in one family. Moreover, the relative frequency of the δ-mutants was quite different from that found among heterozygotes. The new allele δ-cod 5 CCT>ACT, in cis to the allele β+ thal IVS-I-110 G>A, was found in five carriers of a Sicilian family. The new variant δ5(A2)Pro→Thr, named HbA2-Partinico upon the origin of the family, was detected with high-performance liquid chromatography; it overlapped the HbA2 peak which was partially split. The double in cis heterozygotes had increased percentage of normal and variant HbA2 of comparable size. The variant originated most likely from a new mutational event because it was associated with RFLP haplotype I, commonly found with the β+ thal IVS-I-110 G>A, even if crossing over or gene conversion cannot be excluded.
Literature
1.
go back to reference Lacerra G, Musollino G, Scarano C, Lagona LF, Caruso DG, Testa R, Prezioso R, Di Noce F, Medulla E, Friscia MG, Mastrullo L, Caldora M, Nota L, Gaudiano C, Magnano C, Ciaccio C, Romeo MA, Carestia C (2008) Molecular evidences of single mutational events followed by recurrent crossing-overs in the common delta-globin alleles in the Mediterranean area. Gene 410(1):129–138CrossRefPubMed Lacerra G, Musollino G, Scarano C, Lagona LF, Caruso DG, Testa R, Prezioso R, Di Noce F, Medulla E, Friscia MG, Mastrullo L, Caldora M, Nota L, Gaudiano C, Magnano C, Ciaccio C, Romeo MA, Carestia C (2008) Molecular evidences of single mutational events followed by recurrent crossing-overs in the common delta-globin alleles in the Mediterranean area. Gene 410(1):129–138CrossRefPubMed
2.
go back to reference Weatherall DJ, Clegg JB (2001) The thalassaemia syndromes, 4th edn. Blackwell Science, Oxford Weatherall DJ, Clegg JB (2001) The thalassaemia syndromes, 4th edn. Blackwell Science, Oxford
4.
go back to reference Giambona A, Passarello C, Ruggeri G, Renda D, Teresi P, Anzà M, Maggio A (2006) Analysis of delta-globin gene alleles in the Sicilian population: identification of five new mutations. Haematologica 91(12):1681–1684PubMed Giambona A, Passarello C, Ruggeri G, Renda D, Teresi P, Anzà M, Maggio A (2006) Analysis of delta-globin gene alleles in the Sicilian population: identification of five new mutations. Haematologica 91(12):1681–1684PubMed
5.
go back to reference Giambona A, Passarello C, Vinciguerra M, Li Muli R, Teresi P, Anzà M, Ruggeri G, Renda D, Maggio A (2008) Significance of borderline hemoglobin A2 values in an Italian population with a high prevalence of beta-thalassemia. Haematologica 93(9):1380–1384CrossRefPubMed Giambona A, Passarello C, Vinciguerra M, Li Muli R, Teresi P, Anzà M, Ruggeri G, Renda D, Maggio A (2008) Significance of borderline hemoglobin A2 values in an Italian population with a high prevalence of beta-thalassemia. Haematologica 93(9):1380–1384CrossRefPubMed
6.
go back to reference Morgado A, Picanço I, Gomes S, Miranda A, Coucelo M, Seuanes F, Seixas MT, Romão L, Faustino P (2007) Mutational spectrum of delta-globin gene in the Portuguese population. Eur J Haematol 79(5):422–428CrossRefPubMed Morgado A, Picanço I, Gomes S, Miranda A, Coucelo M, Seuanes F, Seixas MT, Romão L, Faustino P (2007) Mutational spectrum of delta-globin gene in the Portuguese population. Eur J Haematol 79(5):422–428CrossRefPubMed
7.
go back to reference Trifillis P, Ioannou P, Schwartz E, Surrey S (1991) Identification of four novel delta-globin gene mutations in Greek Cypriots using polymerase chain reaction and automated fluorescence-based DNA sequence analysis. Blood 78(1):3298–3305PubMed Trifillis P, Ioannou P, Schwartz E, Surrey S (1991) Identification of four novel delta-globin gene mutations in Greek Cypriots using polymerase chain reaction and automated fluorescence-based DNA sequence analysis. Blood 78(1):3298–3305PubMed
8.
go back to reference Tzetis M, Traeger-Synodinos J, Kanavakis E, Metaxotou-Mavromati A, Kattamis C (1994) The molecular basis of normal HbA2 (type 2) beta-thalassemia in Greece. Hematol Pathol 8(1–2):25–34PubMed Tzetis M, Traeger-Synodinos J, Kanavakis E, Metaxotou-Mavromati A, Kattamis C (1994) The molecular basis of normal HbA2 (type 2) beta-thalassemia in Greece. Hematol Pathol 8(1–2):25–34PubMed
9.
go back to reference Moi P, Loudianos G, Lavinha J, Murru S, Cossu P, Casu R, Oggiano L, Longinotti M, Cao A, Pirastu M (1992) Delta-thalassemia due to a mutation in an erythroid-specific binding protein sequence 3′ to the delta-globin gene. Blood 79(2):512–516PubMed Moi P, Loudianos G, Lavinha J, Murru S, Cossu P, Casu R, Oggiano L, Longinotti M, Cao A, Pirastu M (1992) Delta-thalassemia due to a mutation in an erythroid-specific binding protein sequence 3′ to the delta-globin gene. Blood 79(2):512–516PubMed
10.
go back to reference De Angioletti M, Lacerra G, Sabato V, Carestia C (2004) Beta+45 G→C: a novel silent beta-thalassaemia mutation, the first in the Kozak sequence. Br J Haematol 124(2):224–231CrossRefPubMed De Angioletti M, Lacerra G, Sabato V, Carestia C (2004) Beta+45 G→C: a novel silent beta-thalassaemia mutation, the first in the Kozak sequence. Br J Haematol 124(2):224–231CrossRefPubMed
11.
go back to reference Chong SS, Boehm CD, Higgs DR, Cutting GR (2000) Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood 95(1):360–362PubMed Chong SS, Boehm CD, Higgs DR, Cutting GR (2000) Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood 95(1):360–362PubMed
12.
go back to reference Lacerra G, Musollino G, Di Noce F, Prezioso R, Carestia C (2007) Genotyping for known Mediterranean alpha-thalassemia point mutations using a multiplex amplification refractory mutation system. Haematologica 92(2):254–255CrossRefPubMed Lacerra G, Musollino G, Di Noce F, Prezioso R, Carestia C (2007) Genotyping for known Mediterranean alpha-thalassemia point mutations using a multiplex amplification refractory mutation system. Haematologica 92(2):254–255CrossRefPubMed
13.
go back to reference Lacerra G, Testa R, De Angioletti M, Schilirò G, Carestia C (2003) Hb Bronte or alpha93(FG5)Val→Gly: a new unstable variant of the alpha2-globin gene, associated with a mild alpha(+)-thalassemia phenotype. Hemoglobin 27(3):149–159CrossRefPubMed Lacerra G, Testa R, De Angioletti M, Schilirò G, Carestia C (2003) Hb Bronte or alpha93(FG5)Val→Gly: a new unstable variant of the alpha2-globin gene, associated with a mild alpha(+)-thalassemia phenotype. Hemoglobin 27(3):149–159CrossRefPubMed
14.
go back to reference Kulozik AE, Lyons J, Kohne E, Bartram CR, Kleihauer E (1988) Rapid and non-radioactive prenatal diagnosis of beta thalassaemia and sickle cell disease: application of the polymerase chain reaction (PCR). Br J Haematol 70(4):455–458CrossRefPubMed Kulozik AE, Lyons J, Kohne E, Bartram CR, Kleihauer E (1988) Rapid and non-radioactive prenatal diagnosis of beta thalassaemia and sickle cell disease: application of the polymerase chain reaction (PCR). Br J Haematol 70(4):455–458CrossRefPubMed
15.
go back to reference Fullerton SM, Clegg JB (1994) HpaI, HindIII, and BamHI polymorphisms 3′ of the human beta-globin gene can be detected by a single polymerase chain reaction amplification product. Am J Hematol 47(3):256CrossRefPubMed Fullerton SM, Clegg JB (1994) HpaI, HindIII, and BamHI polymorphisms 3′ of the human beta-globin gene can be detected by a single polymerase chain reaction amplification product. Am J Hematol 47(3):256CrossRefPubMed
16.
go back to reference Sutton M, Bouhassira EE, Nagel RL (1989) Polymerase chain reaction amplification applied to the determination of beta-like globin gene cluster haplotypes. Am J Hematol 32(1):66–69CrossRefPubMed Sutton M, Bouhassira EE, Nagel RL (1989) Polymerase chain reaction amplification applied to the determination of beta-like globin gene cluster haplotypes. Am J Hematol 32(1):66–69CrossRefPubMed
17.
go back to reference Orkin SH, Kazazian HH Jr, Antonarakis SE, Goff SC, Boehm CD, Sexton JP, Waber PG, Giardina PJ (1982) Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster. Nature 296(5858):627–631CrossRefPubMed Orkin SH, Kazazian HH Jr, Antonarakis SE, Goff SC, Boehm CD, Sexton JP, Waber PG, Giardina PJ (1982) Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster. Nature 296(5858):627–631CrossRefPubMed
18.
go back to reference Cao A, Gossens M, Pirastu M (1989) β-Thalassemia mutations in Mediterranean populations. Br J Haematol 71(3):309–312PubMedCrossRef Cao A, Gossens M, Pirastu M (1989) β-Thalassemia mutations in Mediterranean populations. Br J Haematol 71(3):309–312PubMedCrossRef
19.
go back to reference Geourjon C, Deléage G (1995) SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Comput Appl Biosci 11(6):681–684 http://www.expasy.org PubMed Geourjon C, Deléage G (1995) SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Comput Appl Biosci 11(6):681–684 http://​www.​expasy.​org PubMed
20.
go back to reference Bissé E, Schauber C, Zorn N, Epting T, Eigel A, Van Dorsselaer A, Wieland H, Kister J, Kiger L (2003) Hemoglobin Görwihl [alpha2beta(2)5(A2)Pro→Ala], an electrophoretically silent variant with impaired glycation. Clin Chem 49(1):137–143CrossRefPubMed Bissé E, Schauber C, Zorn N, Epting T, Eigel A, Van Dorsselaer A, Wieland H, Kister J, Kiger L (2003) Hemoglobin Görwihl [alpha2beta(2)5(A2)Pro→Ala], an electrophoretically silent variant with impaired glycation. Clin Chem 49(1):137–143CrossRefPubMed
21.
go back to reference Langdown JV, Williamson D, Beresford CH, Gibb I, Taylor R, Deacon-Smith R (1994) A new beta chain variant, Hb Tyne [beta 5(A2)Pro→Ser]. Hemoglobin 18(4–5):333–336CrossRefPubMed Langdown JV, Williamson D, Beresford CH, Gibb I, Taylor R, Deacon-Smith R (1994) A new beta chain variant, Hb Tyne [beta 5(A2)Pro→Ser]. Hemoglobin 18(4–5):333–336CrossRefPubMed
22.
go back to reference Wilson CI, Cave RJ, Lehmann H, Close M, Imai K (1984) Haemoglobin Warwickshire (beta 5 [A2] Pro→Arg). A possible ‘fine tuning’ of 2,3-DPG affinity by beta 5 Pro. FEBS Lett 176(2):331–333CrossRefPubMed Wilson CI, Cave RJ, Lehmann H, Close M, Imai K (1984) Haemoglobin Warwickshire (beta 5 [A2] Pro→Arg). A possible ‘fine tuning’ of 2,3-DPG affinity by beta 5 Pro. FEBS Lett 176(2):331–333CrossRefPubMed
23.
go back to reference Lippi G, Carta MR, Salvagno GL, Bellorio F, Montagnana M, Soffiati G, Guidi GC (2008) Separation of haemoglobin HbE and HbA by the fully automated, high-pressure liquid chromatography Tosoh HLC-723 G7 analyzer. Int J Lab Hematol 30(5):432–436CrossRefPubMed Lippi G, Carta MR, Salvagno GL, Bellorio F, Montagnana M, Soffiati G, Guidi GC (2008) Separation of haemoglobin HbE and HbA by the fully automated, high-pressure liquid chromatography Tosoh HLC-723 G7 analyzer. Int J Lab Hematol 30(5):432–436CrossRefPubMed
Metadata
Title
HbA2-Partinico or δ(A2)Pro→Thr, a new genetic variation in the δ-globin gene in cis to the β+ thal IVS-I-110 G>A, and the heterogeneity of δ-globin alleles in double heterozygotes for β- and δ-globin gene defects
Authors
Giuseppina Lacerra
Clelia Scarano
Gennaro Musollino
Rosario Testa
Romeo Prezioso
Daniela G. Caruso
Laura F. Lagona
Emilia Medulla
Maria G. Friscia
Carlo Gaudiano
Clementina Carestia
Publication date
01-02-2010
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 2/2010
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-009-0784-9

Other articles of this Issue 2/2010

Annals of Hematology 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine